A prominent cosmetic surgeon and his daughter have lost a 2017 paper on treating men with excessive neck flab — otherwise known as “turkey neck” — because much of the work appears to have duplicated a book chapter he co-authored about the topic.
The first author of the retracted article is Ronald L. Moy, a plastic surgeon to the stars in Beverly Hills, Calif., and a past president of both the American Academy of Dermatology and the American Society of Dermatology. In a 2012 article about area plastic surgeons, LA Confidential Magazine dubbed Moy the “youth guru” and a local leader in the use of “new research and a comprehensive approach to restore a youthful complexion—no cutting required.”
A group of researchers have retracted their 2016 case report about a rare dermatologic disorder in the wake of disputes about authorship and institutional approval.
The paper describes a young boy with Job’s Syndrome, in which patients experience painful, itchy and frequently disfiguring skin lesions, along with a constellation of other possible symptoms. The condition is extremely rare, occurring in less than one in 1 million births.
This isn’t the first time a journal has retracted a case study after another group of authors claimed ownership of the case. Earlier this year, we covered a retraction from a neuro-ophthalmology journal after the doctors who treated a patient suffering from a gruesome eye trauma took issue with the fact that radiologists had already published their diagnostic images as a case study.
According to the notice for this latest retraction:
Researchers have agreed to pull a 2015 study exploring whether a plant extract can safeguard tanners from ultraviolet exposure after not obtaining formal approval from an ethics committee.
According to the first author, the problem lay in a misunderstanding – when they originally applied for approval six years ago, the researchers believed they didn’t need to go through a formal approval process, since the compound was commercially available without a prescription. Once they realized their mistake, they chose to retract the paper.
A paper on a filler for eye wrinkles did not disclose that it was funded by a pharmaceutical company that produces the cosmetic.
The paper explicitly noted that the authors do not have any financial conflicts of interest, and that a government program supported the study. According to the journal, a reader alerted them to the conflict of interest.
The cooperate tie wasn’t a secret, though — one of the authors was listed as affiliated with the company, Pharma Research Products, based in Korea.
The journal is chalking it up to an “administrative error” that caused it to publish a paper that had already appeared in two other outlets.
According to one of the authors, the “most junior” author published the paper in 2008 in the The Egyptian Journal of Hospital Medicine “without informing other authors.”
When first author Ahmad Settin and the other authors sent it to the IJD in 2009, they were told its small sample size made it a letter to the editor; they decided to “decline submission” and send it to to Acta Dermatovenerologica Alpina, Pannonica et Adriatica, where it waspublished later that year. When Acta discovered the first version, it retracted the paper in 2013.
Meanwhile, editors at the IJD ended up posting the article, “Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt,” in 2011 without telling the authors. So they, too, now have to retract it:
The Journal of Cosmetic and Laser Therapy has retracted a 2014 paper by a group of South Korean researchers after determining that the authors had doubled up on their publishing odds by submitting the manuscript to a competing journal.
The article was titled “A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner’s solution in melasma patients,” and it purported to find that:
This study suggests Jessner’s peel is a safe and effective method in the early course of treatment for melasma when combined with low-fluence 1064-nm Q-switched Nd:YAG laser.
The Journal of the American Academy of Dermatology has issued an expression of concern about a 2012 article reporting the experience of military burn unit treating a rare ailment called toxic epidermal necrolysis.
A Boston doctor indicted on charges of Medicare fraud in 2007 has had a paper relating to the case retracted this month.
Abdul Razzaque Ahmed was considered something of a miracle worker by his patients, treating two rare and disfiguring skin conditions called pemphigoid and pemphigus vulgaris. He used more powerful medicines than the typical course of treatment, including a drug normally used to treat cancer.
The initial indictment stated that Ahmed mixed blood samples to falsely show a “dual diagnosis” of both diseases, and prove to Medicare that they required the more rigorous (and expensive) treatment. It also alleged that he profited massively from the government pay-outs. He was convicted of obstruction in 2007; the other charges were dropped when he agreed to forfeit assets worth $2.9 million.